Location History:
- Palo Alto, CA (US) (2009 - 2011)
- San Diego, CA (US) (2013)
Company Filing History:
1 out of 94 
1 out of 54 
1 out of 99 Years Active: 2009-2013
Title: The Innovative Contributions of Mitchell Koolpe
Introduction
Mitchell Koolpe is a notable inventor based in Palo Alto, CA (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of Eph receptor activity. With a total of 3 patents, Koolpe's work has implications for therapeutic applications in various diseases.
Latest Patents
Koolpe's latest patents include innovative agents that modulate Eph receptor activity. These novel agents bind to Eph receptors and provide methods for stimulating apoptosis and delivering therapeutic agents. Additionally, he has developed methods for screening agents capable of selectively binding to Eph receptors. Another significant patent involves EphB receptor-binding peptides, which are identified for their selective binding to Eph receptors of the B class. The applications of these peptides extend to the treatment of various diseases, including the imaging of tumors in patients through the administration of labeled peptides.
Career Highlights
Throughout his career, Koolpe has worked with esteemed organizations such as the Burnham Institute and the Burnham Institute for Medical Research. His research has contributed to advancements in understanding Eph receptor functions and their potential therapeutic uses.
Collaborations
Koolpe has collaborated with notable colleagues, including Elena B Pasquale and Keith K Murai. These collaborations have further enriched his research and innovation in the field.
Conclusion
Mitchell Koolpe's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications targeting Eph receptors.